An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia
NCT01395615 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2016-11-02
Summary
This observational study will assess the health related quality of life (HQRL) profiles of patients with chronic lymphocytic leukaemia. Using health assessment questionnaires, data will be collected from patients currently receiving therapy and from those who have finished therapy and have undergone an assessment of treatment.
Conditions
- Lymphocytic Leukemia, Chronic
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Clinical Trials · Hoffmann-La Roche
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
NCT00751296 ·Status: TERMINATED ·Phase: PHASE2
-
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
NCT04872621 ·Status: COMPLETED
-
Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia
NCT01380587 ·Status: COMPLETED
-
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
NCT07030400 ·Status: RECRUITING
-
Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness
NCT03881592 ·Status: UNKNOWN
-
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
NCT05893836 ·Status: COMPLETED
-
Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients
NCT05899543 ·Status: NOT_YET_RECRUITING
-
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom
NCT05557695 ·Status: RECRUITING
-
Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia
NCT03971565 ·Status: UNKNOWN
-
Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia
NCT04699162 ·Status: COMPLETED
-
AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database
NCT06548152 ·Status: RECRUITING
-
Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
NCT05665374 ·Status: COMPLETED
-
MEOI and HRQoL in CLL Patients Treated With BTKis
NCT04938141 ·Status: COMPLETED
-
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
NCT03059251 ·Status: COMPLETED
-
the Real World Study of Orelabrutinib in the Treatment of CLL/SLL
NCT05975164 ·Status: UNKNOWN
-
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
NCT05246345 ·Status: RECRUITING
-
Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
NCT05371808 ·Status: RECRUITING
-
A Prognostic Tool for Early Stage CLL
NCT03436524 ·Status: COMPLETED
-
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
NCT04016636 ·Status: COMPLETED
-
Chronic Myeloid Leukemia (CML) Real-Life Database
NCT05963061 ·Status: RECRUITING
-
International Chronic Myeloid Leukemia Pediatric Study
NCT01281735 ·Status: RECRUITING
-
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
NCT03421626 ·Status: COMPLETED
-
A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities
NCT02915224 ·Status: COMPLETED
-
Lenalidomide in Patients With Chronic Myelomonocytic Leukemia
NCT01368757 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
NCT03647215 ·Status: COMPLETED